Cited by 310Viral Infections and Immunology ResearchCOVID-19 Clinical Research StudiesKawasaki Disease and Coronary Complications

Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021

Open access
Boehmer, Tegan K., Kompaniyets, Lyudmyla, Lavery, Amy M., Hsu, Joy, Ko, Jean Y., Yusuf, Hussain, Romano, Sebastian D., Gundlapalli, Adi V. +2 more·2021·MMWR. Morbidity and Mortality Weekly Report

Abstract

Viral infections are a common cause of myocarditis, an inflammation of the heart muscle (myocardium) that can result in hospitalization, heart failure, and sudden death (1). Emerging data suggest an association between COVID-19 and myocarditis (2-5). CDC assessed this association using a large, U.S. hospital-based administrative database of health care encounters from >900 hospitals. Myocarditis inpatient encounters were 42.3% higher in 2020 than in 2019. During March 2020-January 2021, the period that coincided with the COVID-19 pandemic, the risk for myocarditis was 0.146% among patients diagnosed with COVID-19 during an inpatient or hospital-based outpatient encounter and 0.009% among patients who were not diagnosed with COVID-19. After adjusting for patient and hospital characteristics, patients with COVID-19 during March 2020-January 2021 had, on average, 15.7 times the risk for myocarditis compared with those without COVID-19 (95% confidence interval [CI] = 14.1-17.2); by age, risk ratios ranged from approximately 7.0 for patients aged 16-39 years to >30.0 for patients aged <16 years or ≥75 years. Overall, myocarditis was uncommon among persons with and without COVID-19; however, COVID-19 was significantly associated with an increased risk for myocarditis, with risk varying by age group. These findings underscore the importance of implementing evidence-based COVID-19 prevention strategies, including vaccination, to reduce the public health impact of COVID-19 and its associated complications.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15585/mmwr.mm7035e5

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • COVID-19-associated myocarditis incidence ranged from 150 to 4000 cases per 100,000 individuals.

    “with COVID ranging from 150 to 4000 cases/100 000 individuals”

    From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [85]

    The paper’s overall results report a 0.146% myocarditis risk among hospital-encounter patients diagnosed with COVID-19, approximately 146 per 100,000 and close to the claimed lower bound. They do not support a range reaching 4,000 per 100,000; the reported 4.0% figure is the proportion of the cohort diagnosed with COVID-19, not the myocarditis risk. (LLM, conf=0.90)

    Experimental — accuracy not yet measured
  • The overall incidence of myocarditis in the United States from SARS-CoV-2 infection has been estimated by the Centers for Disease Control and Prevention at around 150 cases per 100,000 versus 9 cases per 100,000 individuals in non-COVID cases during the same time period.

    “The overall incidence of myocarditis in the United States from SARSCoV-2 infection has been estimated in a study by the Centers for Disease Control and Prevention at around 150 cases/100 000 versus 9 cases/100 000 individuals in non-COVID cases during the same time period (Table 1).”

    From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [85]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 11 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Boehmer, T. K., Kompaniyets, L., Lavery, A. M., Hsu, J., Ko, J. Y., Yusuf, H., Romano, S. D., Gundlapalli, A. V., Oster, M. E., & Harris, A. M.
Affiliations
Centers for Disease Control and Prevention (US)
Corresponding author
Boehmer, Tegan K.
Venue
MMWR. Morbidity and Mortality Weekly Report
Published
2021-09-03
Volume
70
Issue
35
Pages
1228-1232
ISSN
  • 0149-2195 (ISSN-L)
  • 1545-861X
OpenAlex
W3197576044
Cited by
310
References
11
Citations by year
2026: 20 · 2025: 35 · 2024: 56 · 2023: 76 · 2022: 104 · 2021: 19
FWCI
42.74
Type
journal article
Language
en
Open access
Locations
  • MMWR Morbidity and Mortality Weekly Report (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, public-domain)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
Funders
Centers for Disease Control and Prevention
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Viral Infections and Immunology Research
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Surgery › Kawasaki Disease and Coronary Complications
Keywords
COVID-19 pandemic, myocarditis, SARS-CoV-2, hospitalization, COVID-19 prevention, COVID-19 vaccination
MeSH terms
COVID-19, Adolescent, Adult, Aged, Female, Humans, Male, Medical Records, Middle Aged, Myocarditis, Risk Factors, United States, Databases, Factual, Risk Assessment, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review